Medical/Pharmaceuticals
111, Inc. Regains Compliance with NASDAQ Requirement
SHANGHAI, Feb. 11, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream inChina, announced today that it has recei...
2025-02-11 21:00
2412
Cubresa and Siemens Healthineers Sign Global Master Interface Agreement for the Cubresa BrainPET™ Scanner
WINNIPEG, MB, Feb. 11, 2025 /PRNewswire/ -- Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract designed to support development efforts and compatibility testing of the Cubresa BrainPET™ scanner in Siem...
2025-02-11 21:00
2225
ZIWIG ENDOTEST®: FAST-TRACK REIMBURSEMENT FOR 25 000 PATIENTS FOR FIRST SALIVA TEST TO DIAGNOSE ENDOMETRIOSIS IN 80 MEDICAL CENTERS IN FRANCE
LYON, France, Feb. 11, 2025 /PRNewswire/ -- Ziwig, a French biotech company committed to advancing women's health, announces the fast-track reimbursement of Ziwig Endotest® - the first saliva diagnostic test for endometriosis- for 25 000 patients across 80 medical centers inFrance thanks to the I...
2025-02-11 20:07
3719
GC Biopharma Shares Research Updates on Rare Disorder Drugs at the WORLD Symposium 2025
YONGIN, South Korea , Feb. 11, 2025 /PRNewswire/ -- GC Biopharma, a South Korean biopharmaceutical company, announced onFeb. 10th that it presented development updates on its LSD (lysosomal storage disorder) pipelines at the WORLD Symposium 2025, held fromFeb. 3rd to 7th, 2025, in San Diego, USA....
2025-02-11 16:40
1996
Infinitus Secures Approval for National-Level Joint Laboratory Project, Ushering in a New Chapter of China-Europe Scientific Research Collaboration
GUANGZHOU, China, Feb. 10, 2025 /PRNewswire/ – In a significant announcement at the recent Infinitus Global Annual Meeting, Infinitus (China) Company Ltd. secured approval for its Sino-British Joint Laboratory on Health and Aging project. This initiative is part of the intergovernmental internati...
2025-02-11 15:27
2933
Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China
LEBANON, N.H., Feb. 11, 2025 /PRNewswire/ -- Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its global distribution network with the opening of a new distribution center in Beijing, China, in March 2025. This expansion marks the lates...
2025-02-11 15:00
2151
Bangkok Dusit Medical Services and CNN joined forces to address global health challenges and explore next-gen solutions
HONG KONG, Feb. 10, 2025 /PRNewswire/ -- Bangkok Dusit Medical Services Public Company Limited (BDMS), the largest private healthcare network inThailand, has continued its long-term partnership with CNN International Commercial (CNNIC) through the sponsorship ofVital Signs hosted by Dr. Sanjay Gu...
2025-02-10 17:16
3195
WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year
* Ranked among the top 1% of companies assessed in the pharmaceutical industry * Recognized as a leader in Green CRDMO, driving innovation for a healthier future * Committed to creating long-term value for all stakeholders SHANGHAI, Feb. 10, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2...
2025-02-10 17:00
2675
BioRay's ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA
SHANGHAI, Feb. 10, 2025 /PRNewswire/ -- On December 19, 2024, BioRay Pharmaceutical Co., Ltd. ("BioRay") announced that the National Medical Products Administration (NMPA) has accepted the clinical trial application for its self-developed Class 1 innovative therapeutic biological product, BR111 f...
2025-02-10 15:32
2280
Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met Endpoints
* CBL-514, the world's first investigational drug for large-area localized fat reduction, has demonstrated significant efficacy in its second and the last Phase2b study (CBL-0205) before Phase 3. * 54.2% of participants in the CBL-514 group achieved at least 20% fat volume reduction four week...
2025-02-10 14:15
2271
NUS scientists develop realistic 'micro-gut' model to study the relationship between gut microbes and human diseases
The 3D scalable 'gut-on-a-chip' model enables real-time visualisation of the interactions of gut microbes and the human intestine SINGAPORE, Feb. 10, 2025 /PRNewswire/ -- In a breakthrough for the advanced study of gut health, scientists from theNational University of Singapore (NUS) have develo...
2025-02-10 13:14
2254
CStone Announces Inclusion of Cejemly® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO Guideline
SUZHOU, China, Feb. 9, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that its key product, Cejemly® (sugemalimab), has been included in the Europe...
2025-02-10 12:20
2423
2025 Singclean Global Aesthetic Master Symposium Debuted in France
PARIS, Feb. 10, 2025 /PRNewswire/ -- 2025 IMCAS World Congress, the world's largest scientific aesthetics congress, was grandly held inParis from January 30 to February 1, celebrating its 26th anniversary. SINGCLEAN highlight video in IMCAS 2025 Singclean Medical showcased its flagship HA fil...
2025-02-10 11:18
1311
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
SHANGHAI, Feb. 9, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first subject treated with an allogeneic BCMA CAR-T therapy d...
2025-02-10 08:29
2933
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
CHENGDU, China, Feb. 7, 2025 /PRNewswire/ -- KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of Stapokibart (anti-IL-4Rα monoclonal antibody, trade name: Ka...
2025-02-08 09:14
5112
'The convergence between of AI and the Biology' LG Creates "Next-Generation Protein Structure Prediction AI" for Drug Discovery
SEOUL, South Korea, Feb. 7, 2025 /PRNewswire/ -- On the 5th, LG AI Research signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu,Seoul, with Prof. Min-Kyung Baek from the school of Biological Sciences at SeoulNational University to develop a "next-generat...
2025-02-07 21:00
4565
Babies Bliss Singapore: Holistic Support for Couples Trying to Conceive During the Festive Season
Helping Couples Navigate Fertility Challenges with Care and Compassion SINGAPORE, Feb. 7, 2025 /PRNewswire/ -- As the festive season approaches, many couples facing fertility challenges experience added emotional stress, making it a vulnerable time for those trying to conceive. Babies Bliss Sing...
2025-02-07 15:09
3298
Bowtie Collaborate with Gleneagles Hospital Hong Kong and Pfizer Hong Kong to Promote Health Education
Aims to boost health awareness for migraine, disease impacting over 900,000 Hongkongers[1] HONG KONG, Feb. 7, 2025 /PRNewswire/ -- Bowtie, Hong Kong's first virtual insurer[2], collaborates with Gleneagles Hospital Hong Kong and Pfizer Hong Kong to promote health education. With the aim of encou...
2025-02-07 14:41
3954
GCCL Wins 2025 Asia-Pacific Customer Value Leadership Award by Frost & Sullivan
- GCCL's "One-Stop Lab Solution" sets the industry benchmark with unmatched competitiveness and a dedication to global excellence. - Continuing its growth as a globally recognized leader in clinical sample analysis, driven by customer-centric values. YONGIN, South Korea, Feb. 7, 2025 /...
2025-02-07 09:31
2570
Nuance Pharma Announces Approval of Ohtuvayre™ (ensifentrine) in Macau SAR, China
Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects SHANGHAI, Feb. 7, 2025 /PRNewswire/ -- Today, Nuance Pharma ("Nuance") announ...
2025-02-07 09:00
6021
Week's Top Stories
Most Reposted
Agoda Launches Agoda Impact Lab at ASEAN Tourism Forum
[Picked up by 318 media titles]
2026-01-29 15:06
Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 309 media titles]
2026-01-27 13:00
Nokia Strengthens Edge AI Capabilities Through Strategic Collaboration with Blaize on Hybrid Inference Solutions Across Asia Pacific Regions
[Picked up by 294 media titles]
2026-01-27 18:00
Multi-Award Winning Phuket Marriott Resort & Spa, Merlin Beach: Voted Top 3 Best Family Resort
[Picked up by 283 media titles]
2026-01-30 08:00
True 1000Hz Powerhouse: PHILIPS EVNIA Unleashes the World's First 1000Hz Dual-Mode Gaming Monitor 27M2N5500XD
[Picked up by 282 media titles]
2026-01-29 18:03
